Insulet: Q4 Earnings Snapshot

Insulet: Q4 Earnings Snapshot

Associated Press Finance

Wed, February 18, 2026 at 9:27 PM GMT+9 1 min read

In this article:

  •                                       StockStory Top Pick 
    

    PODD

    +1.48%

ACTON, Mass. (AP) — ACTON, Mass. (AP) — Insulet Corp. (PODD) on Wednesday reported fourth-quarter profit of $101.6 million.

The Acton, Massachusetts-based company said it had net income of $1.44 per share. Earnings, adjusted for one-time gains and costs, came to $1.55 per share.

The results surpassed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $1.48 per share.

The maker of insulin infusion systems posted revenue of $783.8 million in the period, also beating Street forecasts. Ten analysts surveyed by Zacks expected $767.3 million.

For the year, the company reported profit of $247.1 million, or $3.48 per share. Revenue was reported as $2.71 billion.


This story was generated by Automated Insights () using data from Zacks Investment Research. Access a Zacks stock report on PODD at

Terms and Privacy Policy

Privacy Dashboard

More Info

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin